Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Cancer Research|September 19, 2007
Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxaneYi Lisa Lyu, John E Kerrigan, Chao-Po Lin, et al.Biochimie|June 29, 2013
Enterococcal and streptococcal resistance to PC190723 and related compounds: molecular insights from a FtsZ mutational analysisMalvika Kaul, Yongzheng Zhang, Ajit K Parhi, et al.Journal of Medicinal Chemistry|October 12, 2012
A bactericidal guanidinomethyl biaryl that alters the dynamics of bacterial FtsZ polymerizationMalvika Kaul, Ajit K Parhi, Yongzheng Zhang, et al.Breast Cancer Research and Treatment|July 27, 2010
Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypesMadhura S Mehta, Alexei Vazquez, Diptee A Kulkarni, et al.Oncotarget|October 4, 2018
Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancerTazeem Shaik, Gulam M Rather, Nitu Bansal, et al.Oncotarget|March 25, 2014
A novel peptide that inhibits E2F transcription and regresses prostate tumor xenograftsXiaoqi Xie, Nitu Bansal, Tazeem Shaik, et al.Molecular Pharmacology|December 1, 2012
Enhanced degradation of dihydrofolate reductase through inhibition of NAD kinase by nicotinamide analogsYi-Ching Hsieh, Philip Tedeschi, Rialnat Adebisi Lawal, et al.Cancer Biology & Therapy|September 8, 2012
A second target of benzamide riboside: dihydrofolate reductaseBreton Roussel, Nadine Johnson-Farley, John E Kerrigan, et al.Cancer Biology & Therapy|June 25, 2013
Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancerXiaoqi Xie, John E Kerrigan, Tamara Minko, et al.The Journal of Biological Chemistry|June 18, 2009
A G-quadruplex stabilizer induces M-phase cell cycle arrestYuan-Chin Tsai, Haiyan Qi, Chao-Po Lin, et al.Pageof 4